These included alterations in RAD51C, NOTCH4, SMARCA4, SMARCA1 and JAK1 in ovarian endometrioid carcinomas and SMARCA4 genes in ovarian mucinous carcinomas. This evidence concerns the gene SMARCA4 and ovarian endometrioid carcinoma.